Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I

Clinical trial NCT05449405 · COMPLETED

Trial details

NCT number: NCT05449405
Sponsor: Dr. Ferrer BioPharma
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 Symptoms and Signs COVID-19 Pandemic Coronavirus Disease 2019 Coronavirus Infections

Start date: 2021-12-07
Primary completion: 2022-03-11
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.